|
⚲
|
| Ondine Biopharma Corp | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001286774 |
| Sale | 2010-04-05 ($0.0 M Offered, $0.0 M Sold) |
| Fund | |
| Phone | 6046690555 |
| Address | 9101100 Melville St Vancouver, V6E4A6 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Nicolas Loebel | |
| William Harper | |
| Nicholas Loebel | |
| Merrill Biel | |
| Margaret Shaw | |
| Terence Holland | |
| Michael Crane | |
| Colin Watt | |
| Thomas Dawson | |
| Carolyn Cross |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
BlueFocus International Ltd
✚
|
0.0 | |
|
Bluefox Bridgewater LLC
✚
|
0.0 | |
|
Bluegrass Angel Venture Fund IV, LLC
✚
|
0.0 | |
|
Bluegrass Angel Venture Fund V, LLC
✚
|
0.0 | |
|
Blue Heron Capital Fund I, LP
✚
|
0.0 | |
|
Blue Heron Real Estate Opportunity Fund III, LP
✚
|
0.0 | |
|
Blue Heron Real Estate Opportunity Fund IV, LP
✚
|
0.0 | |
|
Blue Hills Bancorp, Inc.
✚
|
0.0 | |
|
Blue Horizon Innovations LC
✚
|
0.0 | |
|
Blue Fish IV, LLC
✚
|
0.0 |